Who Owns BeOne Medicines Stock?
NASDAQ: ONCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 350.13 0.00%
Ownership breakdown
- Held by institutions
- 33.30%
- Held by insiders
- 17.28%
- Institutional holders
- 389
- Institutions 33.3%
- Insiders 17.3%
- Public and other 49.4%
Who owns BeOne Medicines stock?
Institutional investors own about 33.3% of BeOne Medicines's shares, spread across 389 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 17.28% of ONC.
The largest institutional holders are Baker Bros. Advisors, LP (8.02%), Primecap Management Company (4.56%) and Capital International Investors (3.83%). Together, the top 10 institutions control 24.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their ONC positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ONC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Baker Bros. Advisors, LP | 8.80M | 8.02% | +0.0% |
| Primecap Management Company | 5.01M | 4.56% | +0.7% |
| Capital International Investors | 4.21M | 3.83% | +1.2% |
| FMR, LLC | 2.48M | 2.26% | -32.9% |
| Capital World Investors | 2.25M | 2.05% | +38.6% |
| Citadel Advisors Llc | 1.43M | 1.30% | +38.1% |
| Temasek Holdings (Private) Ltd | 845.73K | 0.77% | -2.0% |
| Price (T.Rowe) Associates Inc | 758.75K | 0.69% | +40.6% |
| Blackrock Inc. | 694.62K | 0.63% | +5.7% |
| Millennium Management Llc | 543.32K | 0.49% | +165.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ONC
| Fund | Shares | % Held |
|---|---|---|
| NEW PERSPECTIVE FUND | 2.66M | 2.43% |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 2.35M | 2.14% |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 1.18M | 1.08% |
| EuroPacific Growth Fund-EUPAC Fund | 700.82K | 0.64% |
| New World Fund Inc | 677.29K | 0.62% |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 646.09K | 0.59% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 624.13K | 0.57% |
| iShares Trust-iShares Biotechnology ETF | 596.11K | 0.54% |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Growth Fund | 585.09K | 0.53% |
| New Economy Fund | 491.76K | 0.45% |
Frequently asked questions
Who is the largest shareholder of BeOne Medicines?
Baker Bros. Advisors, LP is the largest institutional shareholder of ONC, owning 8.02% of shares outstanding (8.80M shares) as of its latest 13F filing.
What percentage of BeOne Medicines is owned by institutions?
Institutions own about 33.3% of ONC shares and 40.3% of the public float.
How much of BeOne Medicines do insiders own?
Insiders, such as officers and directors, own about 17.28% of ONC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.